Anuh Pharma Share Price
81.10+1.42 (+1.78%)
-6.31% past 1 Year
News
Anuh Pharma guides for 15-20 percent annual steady growth trajectory
Equity
ANUHPHR
Anuh Pharma expects steady annual growth of 15 to 20 percent
Equity
ANUHPHR
Anuh Pharma reports higher Q1 EBITDA and improved margin year on year
Equity
ANUHPHR
Anuh Pharma reports Q1 revenue of Rs 194 crores, up from Rs 186 crores
Equity
ANUHPHR
Anuh Pharma reports higher Q1 net profit year on year
Equity
ANUHPHR
Anuh Pharma informs about newspaper publication
Equity
ANUHPHR
Anuh Pharma reports modest year-on-year improvement in Q4 EBITDA and margin
Equity
ANUHPHR
Anuh Pharma Q4 revenue grows modestly year-on-year, signalling steady business momentum
Equity
ANUHPHR
Anuh Pharma Q4 FY Profit Declines Marginally Year-on-Year Despite Stable Operations
Equity
ANUHPHR
Anuh Pharma reports Profit after tax of 11.68 Crores, in the March 2026 quarter
Equity
ANUHPHR
Anuh Pharma Receives WHO Prequalification for Anti-Malarial Drug Amodiaquine Hydrochloride USP.
Equity
ANUHPHR
Anuh Pharma informs about press release
Equity
ANUHPHR
Anuh Pharma Maharashtra Facility Passes EDQM Audit Successfully
Equity
ANUHPHR
USFDA completes inspection at Anuh Pharma’s Palghar facilities
Equity
ANUHPHR
Anuh Pharma - Quaterly Results
Equity
ANUHPHR
Anuh Pharma Q3 EBITDA Rises 13.5% YoY to Rs 16.80 Crores, Margin Contracts to 8.52%.
Equity
ANUHPHR
Anuh Pharma Q3 FY26 Results: Net Profit Up 31% YoY to Rs 13.50 Crores, Revenue Rises 23% to Rs 197 Crores.
Equity
ANUHPHR
Anuh Pharma reports Profit after tax of 13.45 Crores, in the December 2025 quarter
Equity
ANUHPHR
Anuh Pharma informs about updates
Equity
ANUHPHR
Anuh Pharma surges on getting CEP for Sulfadimethoxine from EDQM
Equity
ANUHPHR